UK Registered Veterinary Retailer

Cephacare for Dogs & Cats Flavour Tablets

Cephacare for Dogs & Cats Flavour Tablets
50mg » Pack of 100

  • 50mg » Pack of 100 £29.99
  • 50mg » Priced per Tablet £0.40
  • 250mg » Pack of 100 £58.99
  • 250mg » Pack of 250 £146.99
  • 250mg » Priced per Tablet £0.59
  • 500mg » Pack of 100 £75.49
  • 500mg » Pack of 250 £188.50
  • 500mg » Priced per Tablet £0.79

Selection of 8 products from

£0.40 to £188.50

Description

Cephacare contains the well known antibiotic cefalexin in a palatable, beef flavoured tablet. It is used to treat infections of the respiratory, urinary, gastro-intestinal systems and the skin. It can also be used for localised soft tissue infections elsewhere in the body. Cephacare is used in dogs and cats. The tablets are given twice daily at a dose rate of 15- 30 mg/kg bodyweight, depending on the nature of the infection.

Dosage and administration

For oral administration. Cephacare flavour tablets have a break mark on one side to enable more accurate dosing. Tablets may also be added to food if necessary.
To avoid underdosing, the bodyweight should be accurately determined.

Dogs
A dose of 15 mg/kg twice daily is recommended, to be doubled where appropriate.
Treatment for five days is recommended. Any increase in dose or duration of use should be according to a risk/benefit assessment by the prescribing veterinarian (e.g. in cases of chronic pyoderma).

Cats
A dose of 15 mg/kg twice daily for 5 days is recommended.

Contra-indications, warnings, etc

For animal treatment only. Use of the product should be based on susceptibility testing and take into account official and local antimicrobial policies.
Use of the product deviating from the instructions given in the SPC may increase the prevalence of bacteria resistant to cefalexin and may decrease the effectiveness of treatment with penicillins, due to the potential for cross resistance.
In the case of an allergic reaction, treatment should be withdrawn.
The administration of cefalexin has been shown to produce no serious side-effects at many times the recommended dose rate.
As with other antibiotics which are excreted mainly by the kidneys, unnecessary accumulation may occur in the body when renal function is impaired. In cases of known renal insufficiency the dose should be reduced, antimicrobials known to be nephrotoxic should not be administered concurrently and the product should be used only according to a risk/benefit assessment by the responsible veterinarian.
The safety of the product has not been demonstrated in studies in pregnant or lactating dogs and cats. Use only in accordance with a risk/benefit assessment by the responsible veterinarian.
Transient episodes of soft faeces and vomiting have been observed in cats when given products containing cefalexin. Treatment should be discontinued if vomiting and diarrhoea develop.
Vomiting has been observed occasionally in dogs when given products containing cefalexin.

Contraindications
Do not use in cases of known hypersensitivity to the active substance to other cephalosporins, to other substances of the b-lactam group or to any of the excipients.
Do not use in rabbits, gerbils, guinea pigs and hamsters.

User warnings
Penicillins and cephalosporins may cause hypersensitivity (allergy) following injection, inhalation, ingestion or skin contact. Hypersensitivity to penicillin may lead to cross-reactions to cephalosporin and vice versa. Allergic reactions to these substances may occasionally be serious. Do not handle this product if you know you are sensitised or if you have been advised not to be in contact with such substances. Handle this product with great care to avoid exposure, taking all recommended precautions. If you develop symptoms following exposure such as skin rash you should seek medical advice and show the doctor this warning. Swelling of the face, lips or eyes or difficulty breathing are more serious symptoms and require urgent medical attention. In case of accidental ingestion, seek medical advice immediately and show the package leaflet or the label to the physician.
Wash hands after use.

Pharmaceutical precautions

Return any tablet to the blister pack and use within 24 hours. Keep the blister pack in the outer carton. Keep out of the reach and sight of children. Do not store above 25C.
Store in a dry place. Do not use after the expiry date stated on blister and carton.

Disposal
Any unused product or waste materials should be disposed of in accordance with national requirements.

Need help or advice? Contact us:

  • Landline: 01582 842096
  • Mon - Fri: 8:30am - 5:00pm
  • Sat: 9:00am - 1:00pm (Collections only)
  • Email: [email protected]

All prices include VAT where applicable.

Medication Datasheets

50mg » Priced per Tablet

SUMMARY OF PRODUCT CHARACTERISTICS

  1. NAME OF THE VETERINARY MEDICINAL PRODUCT

Cephacare flavour 50 mg tablets for cats and dogs

  1. QUALITATIVE AND QUANTITATIVE COMPOSITION

Each tablet contains:

Active substance: 50 mg cefalexin as cefalexin monohydrate.

Excipients: For a full list of excipients, see section 6.1.

  1. PHARMACEUTICAL FORM

Tablets Beige, round biconvex tablets. The tablets should not be divided

  1. CLINICAL PARTICULARS

4.1 Target species

Cats and dogs

4.2 Indications for use, specifying the target species

In dogs: Treatment of infections of the respiratory tract, gastro-intestinal tract, urogenital tract, the skin and localised infections in soft tissue caused by bacteria sensitive to cefalexin.

In cats: Treatment of infections of the respiratory tract, urogenital tract, the skin and localised infections in soft tissue caused by bacteria sensitive to cefalexin.

4.3 Contraindications

Do not use in cases of known hypersensitivity to the active substance, to other cephalosporins, to other substances of the -lactam group or to any of the excipients. Do not use in rabbits, gerbils, guinea pigs and hamsters.

4.4 Special warnings for each target species

None

4.5 Special precautions for use

Special precautions for use in animals

Use of the product should be based on susceptibility testing and take into account official and local antimicrobial policies.

Use of the product deviating from the instructions given in the SPC may increase the prevalence of bacteria resistant to cefalexin and may decrease the effectiveness of treatment with penicillins, due to the potential for cross resistance.

In the case of an allergic reaction, treatment should be withdrawn.

As with other antibiotics which are excreted mainly by the kidneys, unnecessary accumulation may occur in the body when renal function is impaired. In cases of known renal insufficiency the dose should be reduced, antimicrobials known to be nephrotoxic should not be administered concurrently and the product should be used only according to a risk/benefit assessment by the responsible veterinarian.

Special precautions to be taken by the person administering the veterinary medicinal product to animals

Penicillins and cephalosporins may cause hypersensitivity (allergy) following injection, inhalation, ingestion or skin contact. Hypersensitivity to penicillin may lead to cross-reactions to cephalosporin and vice versa. Allergic reactions to these substances may occasionally be serious. Do not handle this product if you know you are sensitised or if you have been advised not to be in contact with such substances.

Handle this product with great care to avoid exposure, taking all recommended precautions. If you develop symptoms following exposure such as skin rash, you should seek medical advice and show the doctor this warning. Swelling of the face, lips or eyes or difficulty breathing are more serious symptoms and require urgent medical attention.

In case of accidental ingestion, seek medical advice immediately and show the package leaflet or the label to the physician.

Wash hands after use.

4.6 Adverse reactions (frequency and seriousness)

Transient episodes of soft faeces and vomiting have been observed in cats when given products containing cefalexin. Treatment should be discontinued if vomiting and diarrhoea develop.

Vomiting has been observed occasionally in dogs when given products containing cefalexin. 4.7 Use during pregnancy, lactation or lay

The safety of the product has not been demonstrated in studies in pregnant or lactating dogs and cats. Use only in accordance with a risk/benefit assessment by the responsible veterinarian.

4.8 Interaction with other medicinal products and other forms of interaction

See section 4.5i Special precautions for use in animals.

The bactericidal activity of cephalosporins is reduced by concomitant administration of bacteriostatic acting compounds (macrolides, sulphonamides and tetracyclines). Nephrotoxicity can be increased when 1st generation cephalosporins are combined with polypeptide antibiotics, aminoglycosides and some diuretics (furosemide). Concomitant use with such active substances should be avoided.

4.9 Amounts to be administered and administration route

For oral administration.

Dogs: A dose of 15 mg/kg twice daily is recommended, to be doubled where appropriate.
Treatment for five days is recommended. Any increase in dose or duration of use should be according to a risk/benefit assessment by the prescribing veterinarian (e.g. in cases of chronic pyoderma).

Cats: A dose of 15 mg/kg twice daily for 5 days is recommended.

Tablets may be added to food if necessary.

To avoid underdosing, the bodyweight should be accurately determined.

4.10 Overdose (symptoms, emergency procedures, antidotes), if necessary

The administration of cefalexin has been shown to produce no serious side-effects at many times the recommended dose rate.

4.11 Withdrawal period(s)

Not applicable.

  1. PHARMACOLOGICAL PROPERTIES

Pharmacotherapeutic group: Antibacterials for systemic use, other beta-lactam antibacterials, first-generation cephalosporins. ATCvet code: QJ01DB01

5.1 Pharmacodynamic properties

Cefalexin is a semi-synthetic bactericidal antibiotic belonging to the cephalosporin group which acts by interference with bacterial cell wall formation.

Cefalexin is active against a wide range of Gram-positive and Gram-negative bacteria. The following micro-organisms have been shown to be sensitive to cefalexin in vitro: Staphylococcus spp (including penicillin-resistant strains), Streptococcus spp, Corynebacterium spp, Pasteurella multocida, Escherichia coli, Micrococcus spp, Moraxella spp.

Cefalexin is resistant to the action of staphylococcal penicillinase and is therefore active against the strains of Staphylococcus aureus that are insensitive to penicillin (or related antibiotics such as ampicillin or amoxycillin) because of production of penicillinase.

Cefalexin is also active against the majority of ampicillin-resistant E.coli.

5.2 Pharmacokinetic particulars

Following oral administration, cefalexin is rapidly and almost completely absorbed. Peak plasma concentrations (Cmax= 14.38 μg/ml) are achieved within approximately 2 hours (Tmax= 2.1 hours) in the cat. Peak plasma concentrations in the dog (Cmax= 17.49 μg/ml) are achieved within approximately 1.5 hours (Tmax= 1.55). In both species, cefalexin is excreted in the urine in high concentrations and has an elimination half life (T1/2) of approximately 2.5–3 hours.

  1. PHARMACEUTICAL PARTICULARS

6.1 List of excipients

Lactose monohydrate Potato starch Magnesium stearate Beef flavour

6.2 Incompatibilities

Not applicable

6.3 Shelf life

Shelf-life of the veterinary medicinal product as packaged for sale: 3 years.

6.4 Special precautions for storage

Do not store above 25C. Store in a dry place. Keep the blister in the outer carton.

6.5 Nature and composition of immediate packaging

Cephacare flavour 50 mg tablets are supplied in PVC/aluminium foil blister packs, each containing 10 tablets, in cardboard boxes containing 20, 100 or 250 tablets.

Not all pack sizes may be marketed.

6.6 Special precautions for the disposal of unused veterinary medicinal product or waste materials derived from the use of such products

Any unused veterinary medicinal product or waste materials derived from such veterinary medicinal products should be disposed of in accordance with local requirements.

  1. MARKETING AUTHORISATION HOLDER

Animalcare Ltd 10 Great North Way York Business Park Nether Poppleton York Yorkshire YO26 6RB

  1. MARKETING AUTHORISATION NUMBER

Vm 10347/4025

  1. DATE OF FIRST AUTHORISATION

19 December 2008

  1. DATE OF REVISION OF THE TEXT

July 2018

Approved: 11 July 2018

250mg » Priced per Tablet

SUMMARY OF PRODUCT CHARACTERISTICS

  1. NAME OF THE VETERINARY MEDICINAL PRODUCT

Cephacare flavour 250 mg tablets for dogs

  1. QUALITATIVE AND QUANTITATIVE COMPOSITION

Each tablet contains:

Active substance: 250 mg cefalexin as cefalexin monohydrate.

Excipients: For a full list of excipients, see section 6.1.

  1. PHARMACEUTICAL FORM

Tablets Beige, flat tablets with a break mark on one side.

  1. CLINICAL PARTICULARS

4.1 Target species

Dogs

4.2 Indications for use, specifying the target species

Treatment of infections of the respiratory tract, gastro-intestinal tract, urogenital tract, the skin and localised infections in soft tissue caused by bacteria sensitive to cefalexin.

4.3 Contraindications

Do not use in cases of known hypersensitivity to the active substance, to other cephalosporins, to other substances of the -lactam group or to any of the excipients. Do not use in rabbits, gerbils, guinea pigs and hamsters.

4.4 Special warnings for each target species

None

4.5 Special precautions for use

Special precautions for use in animals

Use of the product should be based on susceptibility testing and take into account official and local antimicrobial policies.

Use of the product deviating from the instructions given in the SPC may increase the prevalence of bacteria resistant to cefalexin and may decrease the effectiveness of treatment with penicillins, due to the potential for cross resistance.

In the case of an allergic reaction, treatment should be withdrawn.

As with other antibiotics which are excreted mainly by the kidneys, unnecessary accumulation may occur in the body when renal function is impaired. In cases of known renal insufficiency the dose should be reduced, antimicrobials known to be nephrotoxic should not be administered concurrently and the product should be used only according to a risk/benefit assessment by the responsible veterinarian.

Special precautions to be taken by the person administering the veterinary medicinal product to animals

Penicillins and cephalosporins may cause hypersensitivity (allergy) following injection, inhalation, ingestion or skin contact. Hypersensitivity to penicillin may lead to cross-reactions to cephalosporin and vice versa. Allergic reactions to these substances may occasionally be serious. Do not handle this product if you know you are sensitised or if you have been advised not to be in contact with such substances.

Handle this product with great care to avoid exposure, taking all recommended precautions. If you develop symptoms following exposure such as skin rash, you should seek medical advice and show the doctor this warning. Swelling of the face, lips or eyes or difficulty breathing are more serious symptoms and require urgent medical attention.

In case of accidental ingestion, seek medical advice immediately and show the package leaflet or the label to the physician.

Wash hands after use.

4.6 Adverse reactions (frequency and seriousness)

Vomiting has been observed occasionally in dogs when given products containing cefalexin.

4.7 Use during pregnancy, lactation or lay

The safety of the product has not been demonstrated in studies in pregnant or lactating dogs. Use only in accordance with a risk/benefit assessment by the responsible veterinarian.

4.8 Interaction with other medicinal products and other forms of interaction

See section 4.5i Special precautions for use in animals.

The bactericidal activity of cephalosporins is reduced by concomitant administration of bacteriostatic acting compounds (macrolides, sulphonamides and tetracyclines). Nephrotoxicity can be increased when 1st generation cephalosporins are combined with polypeptide antibiotics, aminoglycosides and some diuretics (furosemide). Concomitant use with such active substances should be avoided.

4.9 Amounts to be administered and administration route

For oral administration. A dose of 15 mg/kg twice daily is recommended, to be doubled where appropriate.

Cephacare flavour 250 mg tablets have a break mark on one side. To enable more accurate dosing, half tablets may be used as necessary.

Treatment for five days is recommended. Any increase in dose or duration of use should be according to a risk/benefit assessment by the prescribing veterinarian (e.g. in cases of chronic pyoderma).

Tablets may be added to food if necessary.

To avoid underdosing, the bodyweight should be accurately determined.

The use of cefalexin tablets of lower strengths is advised for dogs with lower bodyweights.

4.10 Overdose (symptoms, emergency procedures, antidotes), if necessary

The administration of cefalexin has been shown to produce no serious side-effects at many times the recommended dose rate.

4.11 Withdrawal period(s)

Not applicable.

  1. PHARMACOLOGICAL PROPERTIES

Pharmacotherapeutic group: Antibacterials for systemic use, other beta-lactam antibacterials, first-generation cephalosporins. ATCvet code: QJ01DB01.

5.1 Pharmacodynamic properties

Cefalexin is a semi-synthetic bactericidal antibiotic belonging to the cephalosporin group which acts by interference with bacterial cell wall formation.

Cefalexin is active against a wide range of Gram-positive and Gram-negative bacteria. The following micro-organisms have been shown to be sensitive to cefalexin in vitro: Staphylococcus spp (including penicillin-resistant strains), Streptococcus spp, Corynebacterium spp, Pasteurella multocida, Escherichia coli, Micrococcus spp, Moraxella spp.

Cefalexin is resistant to the action of staphylococcal penicillinase and is therefore active against the strains of Staphylococcus aureus that are insensitive to penicillin (or related antibiotics such as ampicillin or amoxycillin) because of production of penicillinase.

Cefalexin is also active against the majority of ampicillin-resistant E.coli.

5.2 Pharmacokinetic particulars

Following oral administration, cefalexin is rapidly and almost completely absorbed. Peak plasma concentrations in the dog (Cmax= 17.49 μg/ml) are achieved within approximately 1.5 hours (Tmax= 1.55). Cefalexin is excreted in the urine in high concentrations and has an elimination half life (T1/2) of approximately 2.5–3 hours.

  1. PHARMACEUTICAL PARTICULARS

6.1 List of excipients

Lactose monohydrate Potato starch Magnesium stearate Beef flavour

6.2 Incompatibilities

Not applicable

6.3 Shelf life

Shelf-life of the veterinary medicinal product as packaged for sale: 3 years Return any ½ tablet to the blister pack and use within 24 hours.

6.4 Special precautions for storage

Do not store above 25C. Store in a dry place. Keep the blister in the outer carton.

6.5 Nature and composition of immediate packaging

Cephacare flavour 250 mg tablets are supplied in PVC/aluminium foil blister packs, each containing 10 tablets, in cardboard boxes containing 20, 100 or 250 tablets.

Not all pack sizes may be marketed.

6.6 Special precautions for the disposal of unused veterinary medicinal product or waste materials derived from the use of such products

Any unused veterinary medicinal product or waste materials derived from such veterinary medicinal products should be disposed of in accordance with local requirements. 7. MARKETING AUTHORISATION HOLDER

Animalcare Ltd 10 Great North Way York Business Park Nether Poppleton York Yorkshire YO26 6RB

  1. MARKETING AUTHORISATION NUMBER

    Vm 10347/4026

  2. DATE OF FIRST AUTHORISATION

19 December 1998

  1. DATE OF REVISION OF THE TEXT

July 2018

Approved: 11 July 2018

500mg » Priced per Tablet

SUMMARY OF PRODUCT CHARACTERISTICS

  1. NAME OF THE VETERINARY MEDICINAL PRODUCT

Cephacare flavour 500 mg tablets for dogs

  1. QUALITATIVE AND QUANTITATIVE COMPOSITION

Each tablet contains:

Active substance: 500 mg cefalexin as cefalexin monohydrate.

Excipients: For a full list of excipients, see section 6.1.

  1. PHARMACEUTICAL FORM

Tablets Beige, flat tablets with a break mark on one side.

  1. CLINICAL PARTICULARS

4.1 Target species

Dogs

4.2 Indications for use, specifying the target species

Treatment of infections of the respiratory tract, gastro-intestinal tract, urogenital tract, the skin and localised infections in soft tissue caused by bacteria sensitive to cefalexin.

4.3 Contraindications

Do not use in cases of known hypersensitivity to the active substance, to other cephalosporins, to other substances of the -lactam group or to any of the excipients. Do not use in rabbits, gerbils, guinea pigs and hamsters.

4.4 Special warnings for each target species

None

4.5 Special precautions for use

Special precautions for use in animals

Use of the product should be based on susceptibility testing and take into account official and local antimicrobial policies.

Use of the product deviating from the instructions given in the SPC may increase the prevalence of bacteria resistant to cefalexin and may decrease the effectiveness of treatment with penicillins, due to the potential for cross resistance.

In the case of an allergic reaction, treatment should be withdrawn.

As with other antibiotics which are excreted mainly by the kidneys, unnecessary accumulation may occur in the body when renal function is impaired. In cases of known renal insufficiency the dose should be reduced, antimicrobials known to be nephrotoxic should not be administered concurrently and the product should be used only according to a risk/benefit assessment by the responsible veterinarian.

Special precautions to be taken by the person administering the veterinary medicinal product to animals

Penicillins and cephalosporins may cause hypersensitivity (allergy) following injection, inhalation, ingestion or skin contact. Hypersensitivity to penicillin may lead to cross-reactions to cephalosporin and vice versa. Allergic reactions to these substances may occasionally be serious. Do not handle this product if you know you are sensitised or if you have been advised not to be in contact with such substances.

Handle this product with great care to avoid exposure, taking all recommended precautions. If you develop symptoms following exposure such as skin rash, you should seek medical advice and show the doctor this warning. Swelling of the face, lips or eyes or difficulty breathing are more serious symptoms and require urgent medical attention.

In case of accidental ingestion, seek medical advice immediately and show the package leaflet or the label to the physician.

Wash hands after use.

4.6 Adverse reactions (frequency and seriousness)

Vomiting has been observed occasionally in dogs when given products containing cefalexin.

4.7 Use during pregnancy, lactation or lay

The safety of the product has not been demonstrated in studies in pregnant or lactating dogs. Use only in accordance with a risk/benefit assessment by the responsible veterinarian.

4.8 Interaction with other medicinal products and other forms of interaction

See section 4.5i Special precautions for use in animals.

The bactericidal activity of cephalosporins is reduced by concomitant administration of bacteriostatic acting compounds (macrolides, sulphonamides and tetracyclines). Nephrotoxicity can be increased when 1st generation cephalosporins are combined with polypeptide antibiotics, aminoglycosides and some diuretics (furosemide). Concomitant use with such active substances should be avoided.

4.9 Amounts to be administered and administration route

For oral administration. A dose of 15 mg/kg twice daily is recommended, to be doubled where appropriate.

Cephacare flavour 500 mg tablets have a break mark on one side. To enable more accurate dosing, half tablets may be used as necessary.

Treatment for five days is recommended. Any increase in dose or duration of use should be according to a risk/benefit assessment by the prescribing veterinarian (e.g. in cases of chronic pyoderma).

Tablets may be added to food if necessary.

To avoid underdosing, the bodyweight should be accurately determined.

The use of cefalexin tablets of lower strengths is advised for dogs with lower bodyweights.

4.10 Overdose (symptoms, emergency procedures, antidotes), if necessary

The administration of cefalexin has been shown to produce no serious side-effects at many times the recommended dose rate.

4.11 Withdrawal period(s)

Not applicable.

  1. PHARMACOLOGICAL PROPERTIES

Pharmacotherapeutic group: Antibacterials for systemic use, other beta-lactam antibacterials, first-generation cephalosporins. ATCvet code: QJ01DB01.

5.1 Pharmacodynamic properties

Cefalexin is a semi-synthetic bactericidal antibiotic belonging to the cephalosporin group which acts by interference with bacterial cell wall formation.

Cefalexin is active against a wide range of Gram-positive and Gram-negative bacteria. The following micro-organisms have been shown to be sensitive to cefalexin in vitro: Staphylococcus spp (including penicillin-resistant strains), Streptococcus spp, Corynebacterium spp, Pasteurella multocida, Escherichia coli, Micrococcus spp, Moraxella spp.

Cefalexin is resistant to the action of staphylococcal penicillinase and is therefore active against the strains of Staphylococcus aureus that are insensitive to penicillin (or related antibiotics such as ampicillin or amoxycillin) because of production of penicillinase.

Cefalexin is also active against the majority of ampicillin-resistant E.coli.

5.2 Pharmacokinetic particulars

Following oral administration, cefalexin is rapidly and almost completely absorbed. Peak plasma concentrations in the dog (Cmax= 17.49 μg/ml) are achieved within approximately 1.5 hours (Tmax= 1.55). Cefalexin is excreted in the urine in high concentrations and has an elimination half life (T1/2) of approximately 2.5–3 hours.

  1. PHARMACEUTICAL PARTICULARS

6.1 List of excipients

Lactose monohydrate Potato starch Magnesium stearate Beef flavour

6.2 Incompatibilities

Not applicable

6.3 Shelf life

Shelf-life of the veterinary medicinal product as packaged for sale: 3 years. Return any ½ tablet to the blister pack and use within 24 hours.

6.4 Special precautions for storage

Do not store above 25C. Store in a dry place. Keep the blister in the outer carton.

6.5 Nature and composition of immediate packaging

Cephacare flavour 500 mg tablets are supplied in PVC/aluminium foil blister packs each containing 10 tablets, in cardboard boxes containing 20, 100 or 250 tablets.

Not all pack sizes may be marketed.

6.6 Special precautions for the disposal of unused veterinary medicinal product or waste materials derived from the use of such products

Any unused veterinary medicinal product or waste materials derived from such veterinary medicinal products should be disposed of in accordance with local requirements.

  1. MARKETING AUTHORISATION HOLDER

Animalcare Ltd. 10 Great North Way York Business Park Nether Poppleton York Yorkshire YO26 6RB

  1. MARKETING AUTHORISATION NUMBER

Vm 10347/4027

  1. DATE OF FIRST AUTHORISATION

19 December 2008

  1. DATE OF REVISION OF THE TEXT

July 2018

Approved: 11 July 2018

Delivery Information

How quickly do you deliver?

Under almost all products on our website is an Estimated dispatch time, check this for a delivery prediction specific to the item you are looking to purchase. These badges are updated live based on the stock levels we have and also those of our suppliers - so are usually very accurate, but cannot be guaranteed. In more general terms, we aim to dispatch all orders within 1 working day of receiving payment (and a prescription if required). If we cannot do so within 3 working days we will contact you by email.

What do you charge for delivery?

For UK delivery, we charge the following:

Order Total Weight Delivery
£0-£28.99 Under 2kg £2.99
2kg+ £4.99
£29-£38.99 Under 2kg Free
2kg+ £4.99
£39+ Under 2kg Free
2kg+ Free

Prices quoted are for delivery to all parts of mainland UK except certain Scottish postcodes (where the price is higher for items sent by courier. Delivery of food abroad (including Channel Islands, N. Ireland and other islands around the UK) is charged at a higher price and free delivery is not available. Temperature controlled products, such as Insulin, are also not always subject to the standard and/or free delivery options.

For full information on our delivery charges, including prices on heavy deliveries to Scotland and abroad, see our delivery information page.

We can deliver most items to all around the world, but prices do vary. The majority of light weight orders (less than 1.5kg) can be delivered for a flat rate of £10. For an accurate estimate of the delivery charge, please put the items you require in your basket and use the "Estimate Delivery" system on the shopping basket page (you only need to enter your country and postal/zip code) for a quick quote. For deliveries to the USA you may need to go to the checkout page and enter your full address to get a quote (as some services need your state in order to quote too). For more information on international deliveries, please see our delivery information page.

Delivery of aerosols

Due to restrictions aerosols can't be sent by Royal Mail. We appreciate your understanding.

Delivery of temperature controlled items

Some products, such as insulin and frozen food, need to be delivered in insulated packaging to prevent them from getting too warm (or too cold) during transit from us to you. Purchasing any of these items in your order will result in a £1.99 charge being added to the total to cover the high cost of the insulated packaging materials. You only pay the £1.99 once per order, regardless of how many temperature controlled items you purchase in that order.

How do I cancel or return an order?

Please call us as soon as possible if you need to amend or cancel an order on 01582 842096. If your order has been processed for dispatch we will be unable to cancel or amend the order. You will however be able to return your product for a full refund*.

To return an item, you must contact us by phone or email to arrange this BEFORE posting any product back to us. We will explain the process at this stage for you.

*For full details on returns, see our terms and conditions page.

Reviews (1)

Q & A

There are currently no questions for Cephacare for Dogs & Cats Flavour Tablets - be the first to ask one!